Granulosa	granulosa	O	DISEASE	OTHERS	I
cell	cell	O	DISEASE	OTHERS	I
tumor	tumor	O	DISEASE	OTHERS	I
of	of	O	DISEASE	OTHERS	I
the	the	O	DISEASE	OTHERS	I
ovary	ovary	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
antecedent	antecedent	O	O	O	O
tamoxifen	tamoxifen	CHEMICALS	O	OTHERS	I
use	use	O	O	O	O
.	.	O	O	O	O

BACKGROUND	background	O	O	O	O
:	:	O	O	O	O
Increased	increased	O	O	O	O
attention	attention	O	O	O	O
has	has	O	O	O	O
been	been	O	O	O	O
focused	focused	O	O	O	O
recently	recently	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
estrogenic	estrogenic	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
tamoxifen	tamoxifen	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Review	review	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
literature	literature	O	O	O	O
reveals	reveals	O	O	O	O
an	an	O	O	O	O
association	association	O	O	O	O
between	between	O	O	O	O
tamoxifen	tamoxifen	CHEMICALS	O	OTHERS	I
use	use	O	O	O	O
and	and	O	O	O	O
gynecologic	gynecologic	O	O	O	O
tumors	tumors	O	DISEASE	OTHERS	I
.	.	O	O	O	O

CASE	case	O	O	O	O
:	:	O	O	O	O
A	a	O	O	O	O
52-year-old	52-year-old	O	O	O	O
postmenopausal	postmenopausal	O	O	O	O
woman	woman	O	O	O	O
was	was	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
tamoxifen	tamoxifen	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
stage	stage	O	O	O	O
II	ii	O	O	O	O
estrogen	estrogen	CHEMICALS	O	OTHERS	I
receptor-positive	receptor-positive	O	O	O	O
breast	breast	O	DISEASE	OTHERS	I
carcinoma	carcinoma	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Her	her	O	O	O	O
aspartate	aspartate	CHEMICALS	O	OTHERS	I
transaminase	transaminase	O	O	O	O
and	and	O	O	O	O
alanine	alanine	CHEMICALS	O	OTHERS	I
transaminase	transaminase	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
increase	increase	O	O	O	O
markedly	markedly	O	O	O	O
after	after	O	O	O	O
6	6	O	O	O	O
months	months	O	O	O	O
of	of	O	O	O	O
tamoxifen	tamoxifen	CHEMICALS	O	OTHERS	I
use	use	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
an	an	O	O	O	O
additional	additional	O	O	O	O
17	17	O	O	O	O
months	months	O	O	O	O
of	of	O	O	O	O
elevated	elevated	O	O	O	O
serum	serum	O	O	O	O
transaminases	transaminases	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
found	found	O	O	O	O
to	to	O	O	O	O
have	have	O	O	O	O
a	a	O	O	O	O
stage	stage	O	O	O	O
Ic	ic	O	O	O	O
granulosa	granulosa	O	DISEASE	OTHERS	I
cell	cell	O	DISEASE	OTHERS	I
tumor	tumor	O	DISEASE	OTHERS	I
of	of	O	DISEASE	OTHERS	I
the	the	O	DISEASE	OTHERS	I
ovary	ovary	O	DISEASE	OTHERS	I
.	.	O	O	O	O

CONCLUSION	conclusion	O	O	O	O
:	:	O	O	O	O
Patients	patients	O	O	O	O
with	with	O	O	O	O
tamoxifen-induced	tamoxifen-induced	O	O	O	O
liver	liver	O	O	OTHERS	I
dysfunction	dysfunction	O	O	OTHERS	I
may	may	O	O	O	O
be	be	O	O	O	O
at	at	O	O	O	O
increased	increased	O	O	O	O
risk	risk	O	O	O	O
for	for	O	O	O	O
granulosa	granulosa	O	DISEASE	OTHERS	I
cell	cell	O	DISEASE	OTHERS	I
tumors	tumors	O	DISEASE	OTHERS	I
because	because	O	O	O	O
of	of	O	O	O	O
alterations	alterations	O	O	O	O
in	in	O	O	O	O
tamoxifen	tamoxifen	CHEMICALS	O	OTHERS	I
metabolism	metabolism	O	O	O	O
.	.	O	O	O	O

